CINQAIR (Teva Respiratory, LLC)
Welcome to the PulseAid listing for the CINQAIR drug offered from Teva Respiratory, LLC. This Interleukin-5 Antagonist [EPC],Interleukin-5 Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Respiratory, LLC |
| NON-PROPRIETARY NAME: | Reslizumab |
| SUBSTANCE NAME: | RESLIZUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Interleukin-5 Antagonist [EPC],Interleukin-5 Antagonists [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2016-04-18 |
| END MARKETING DATE: | 0000-00-00 |
CINQAIR HUMAN PRESCRIPTION DRUG Details:
| Item Description | CINQAIR from Teva Respiratory, LLC |
| LABELER NAME: | Teva Respiratory, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/mL) |
| START MARKETING DATE: | 2016-04-18 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 59310-610_6583781a-c062-400d-8b2d-4ae8668e31b8 |
| PRODUCT NDC: | 59310-610 |
| APPLICATION NUMBER: | BLA761033 |
Other RESLIZUMAB Pharmaceutical Manufacturers / Labelers:
